GlassScriptPhysician profile
William Stephen Murphy
NPI 1962070912
$525,167.01
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $251K · 2023: $273K · 2024: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $271K · Travel and Lodging: $2,054 · Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $270,809.00 |
| Travel and Lodging | $2,053.73 |
| Food and Beverage | $973.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Planning Associates, INC. | $522,020.02 | 2022-2023 | Hipxpert System |
| Abbvie INC. | $2,526.30 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $140.82 | 2022-2024 | Libtayo |
| Dermavant Sciences, INC. | $138.28 | 2024 | Vtama |
| Janssen Biotech, INC. | $130.01 | 2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $101.02 | 2023 | Sotyktu |
| Zimmer Biomet Holdings, INC. | $90.58 | 2023-2024 | G7, Trabecular Metal, Echo |
| Biofrontera INC. | $19.98 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$141,464.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.